Dr Tracy Putoczki
Honorary (Principal Fellow)
Department of Medical Biology (WEHI)
103 Scholarly works
5 Projects
HIGHLIGHTS
2026
Journal article
Innate lymphoid cells activated by the cytokine TL1A link colitis to emergency granulopoiesis and the recruitment of tumor-promoting neutrophils
DOI: 10.1016/j.immuni.2025.12.0082026
Journal article
The kinase domain of RIPK3 tunes its scaffolding functions
DOI: 10.1038/s41418-026-01677-x2025
Journal article
Relative importance of the anti-apoptotic versus apoptosis-unrelated functions of MCL-1 invivo
DOI: 10.1126/science.adw18362025
Journal article
Inhibition of the minor spliceosome restricts the growth of a broad spectrum of cancers
DOI: 10.1038/s44319-025-00511-82022
Research grants (other domestic)
A New Therapeutic Opportunity for Gastrointestinal Cancers
2018
Research Grant
Development of an Interleukin-11 Signalling Antagonist
2016
Research Grant
The Australian Pancreatic Cancer Organoid Biobank
RECENT SCHOLARLY WORKS
2025
Journal article
The structure of the IL-11 signalling complex provides insight into receptor variants associated with craniosynostosis
DOI: 10.1111/febs.173072025
Journal article
A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID
DOI: 10.1038/s41467-025-57905-42024
Journal article
Identification of Serum Biomarkers to Monitor Therapeutic Response in Intestinal-Type Gastric Cancer
DOI: 10.3390/ijms250631292024
Journal article
Unbiased Quantitative Proteomics of Organoid Models of Pancreatic Cancer
DOI: 10.1007/978-1-0716-3922-1_62023
Journal article
Structures of the interleukin 11 signalling complex reveal gp130 dynamics and the inhibitory mechanism of a cytokine variant
DOI: 10.1038/s41467-023-42754-w2023
Journal article
The E3 ubiquitin ligase NEDD4 regulates chemoresistance to 5-fluorouracil in colorectal cancer cells by altering JNK signalling
DOI: 10.1038/s41419-023-06349-z
RECENT PROJECTS
2025
Research grants (other domestic)
Netrin-1 Neutralisation as a New Therapeutic Strategy Against Pancreatic Cancer
2021
Research Grant
A Sequential CRISPR Approach to Rationally Design Robust Combination Treatments in Pancreatic Cancer